Skip to main content

Table 6 Response rate of each of the five symptoms before and after Treatment

From: Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial

Symptoms

IFNα1b

Group

Control

Group

W

P

Coughing

0.61 ± 0.40

0.52 ± 0.40

3706.5

0.156

Expectoration

0.70 ± 0.44

0.53 ± 0.49

3897.5

0.024

Chest pain

0.16 ± 0.37

0.20 ± 0.40

3182

0.535

Pulmonary rales

0.49 ± 0.49

0.34 ± 0.46

3799.5

0.042

Respiratory rate

0.43 ± 0.50

0.32 ± 0.47

3677.5

0.141

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us